发明公开
EP3016970A1 O-MANNOSYLTRANSFERASE DEFICIENT FILAMENTOUS FUNGAL CELLS AND METHODS OF USE THEREOF
审中-公开
O-MANNOSYLTRANSFERASEDEFIZIENTEFILAMENTÖSEPILZZELLEN UND VERFAHREN ZUR VERWENDUNG DAVON
- 专利标题: O-MANNOSYLTRANSFERASE DEFICIENT FILAMENTOUS FUNGAL CELLS AND METHODS OF USE THEREOF
- 专利标题(中): O-MANNOSYLTRANSFERASEDEFIZIENTEFILAMENTÖSEPILZZELLEN UND VERFAHREN ZUR VERWENDUNG DAVON
-
申请号: EP14734515.1申请日: 2014-07-03
-
公开(公告)号: EP3016970A1公开(公告)日: 2016-05-11
- 发明人: NATUNEN, Jari , HILTUNEN, Jukka , HUUSKONEN, Anne , SALOHEIMO, Markku , OSTERMEIER, Christian , SOMMER, Benjamin Patrick , WAHL, Ramon
- 申请人: Novartis AG , Glykos Finland Oy
- 申请人地址: Lichtstrasse 35 4056 Basel CH
- 专利权人: Novartis AG,Glykos Finland Oy
- 当前专利权人: Novartis AG,Glykos Finland Oy
- 当前专利权人地址: Lichtstrasse 35 4056 Basel CH
- 代理机构: Cabinet Plasseraud
- 优先权: EP13175141 20130704
- 国际公布: WO2015001049 20150108
- 主分类号: C07K14/37
- IPC分类号: C07K14/37 ; C07K16/00
摘要:
The present disclosure relates to compositions and methods useful for the production of heterologous proteins with reduced O-mannosylation in filamentous fungal cells, such as Trichoderma cells. More specifically, the invention provides a PMT-deficient filamentous fungal cell comprising a) at least a first mutation that reduces an endogenous protease activity compared to a parental filamentous fungal cell which does not have said first mutation, and, b) at least a second mutation in a PMT gene that reduces endogenous O-mannosyltransferase activity compared to a parental filamentous fungal cell which does not have said second mutation, wherein said filamentous fungal cell is selected from the group consisting of Trichoderma, Neurospora, Myceliophthora or Chrysosporium cell.
公开/授权文献
信息查询